These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 354131)

  • 1. Anti-donor cell-mediated responses. Pretransplant lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Jun; 10(2):425-7. PubMed ID: 354131
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1978 Jun; 10(2):433-4. PubMed ID: 354133
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant immune monitoring of donor-recipient compatibility.
    Thomas F; Thomas J; Mendez G; Lee HM
    Transplant Proc; 1978 Jun; 10(2):429-32. PubMed ID: 354132
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody and lymphocyte-mediated immunologic recipient versus donor reactions before and after human renal allotransplantation--a prospective study.
    Grunnet N; Kristensen T
    Transplant Proc; 1978 Sep; 10(3):531-3. PubMed ID: 362630
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
    Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
    J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and antibody-dependent LMC cross-matching in renal transplantation.
    d'Apice AJ; Perez G; Carpenter CB
    Transplant Proc; 1976 Mar; 8(1):115-9. PubMed ID: 769258
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of immunological anti-donor reactivity in renal allotransplanted patients--a prospective study.
    Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen S; Jørgensen F; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1977; (42):46-50. PubMed ID: 356221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-dependent cytotoxicity detected by 51Cr release: a predictor of kidney graft rejection.
    McConnachie PR; Finch WT; Birtch AG
    Transplant Proc; 1984 Dec; 16(6):1448-50. PubMed ID: 6390846
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring of rejection.
    Stiller CR; Sinclair NR
    Transplant Proc; 1979 Mar; 11(1):343-9. PubMed ID: 377654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immune responses after donor-specific transfusion (DSBT).
    Kovithavongs T; Sharma R; Schlaut J; Burzminski D; Pazderka F; Harley F; Dossetor JB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1822-4. PubMed ID: 2652592
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-donor immune responses in prediction of transplant rejection.
    Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
    N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
    Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
    Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity (ADCC) and lymphocyte-mediated cytotoxicity (LMC) in patients with vascular disease and guinea pigs immunized with human vascular extracts.
    Horváth M; Varsányi M; Jovanovich N
    Allergol Immunopathol (Madr); 1983; 11(4):261-71. PubMed ID: 6606348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
    Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
    Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of pre- and posttransplant studies of antidonor antibody-dependent cellular cytotoxicity (ADCC).
    Kirchoff C; Thomas F; Edwards E; Thomas J
    Transplant Proc; 1981 Sep; 13(3):1565-8. PubMed ID: 7029816
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-donor antibody responses. Recipient presensitization and renal allograft survival.
    Keown P; Stiller CR; Sinclair NR; Fung M; McGirr D; Moseley P; Howson W; Ulan RA
    Transplant Proc; 1978 Jun; 10(2):459-62. PubMed ID: 354135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.